GC Therapeutics Analysis: $75M Raised
What is GC Therapeutics?
GC Therapeutics utilizes the TFome platform to develop scalable induced pluripotent stem cell therapies. This platform aims to simplify the complexities of cell therapy and enhance patient access across various therapeutic areas. The company is focused on gastrointestinal, neurological, and immunological diseases.
Location
Cambridge, United States
Employees
11-50
Founded
2019
Funding Status
Series A
Product Features & Capabilities
- TFome platform for iPSC cellular programming
- Scalable cell therapy development
- Off-the-shelf iPSC-based medicines
Use Cases
Develop cell therapies for gastrointestinal diseases; Create therapies for neurological conditions; Advance treatments for immunological diseases; Scale production of iPSC-based medicines; Improve patient access to advanced therapies
Other Considerations
Founded by George Church, Ph.D.; Backed by a team of experienced scientists; Focused on addressing healthcare burdens through advanced therapies
See something that needs updating? Suggest edits to this profile.